Diaphorina citri psyllid: psy13635

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------
MDYDDRNFYVHKMMFITNTKWVNYIFLVVHFWYALSHHVAAQMLLFATSKDIRIANLSRPLKPVTIIKDLEEGAAIDYYYKKSMVCWTDHGTEMISCCTFDGNNVGSKHNVITNGLITPDGLAIDWLTEKLYWTDSETNKLEVSSLDGKKRKVLYWEDIDQPRAIASYKLPTIEVEHPDGVAVDWVARNLYWTDTGTDRIEVCRLEGTHRKVLVNTDLVEPRAITLSPAHGYLFWSDWNEKRPKIERSLLNGGERVLLVKDRLGWPNGITLDVDNEKLYWCDAKTDKIEMIDFDGNNRRELINENLPHVFGISLLGDYVYWTDWQRRSIDRVNKITGNDREVIIERSCTGVTRRRTR
ccccccccccccccEEEEccccEEEEccccEEEEcccccccEEEEEEccccEEEEEcccccccEEEEccccccEEEEEEccccEEEEEcccccCEEEEEccccccccEEEEECccccccEEEEEEccccEEEEEEccccEEEEEEccccccEEEEEcccccccccccccccccccccccEEEEEEccccEEEEEccccEEEEEEcccccCEEEEccccccccEEEEEcccccEEEEEcccccccEEEEcccccccEEEEEccccccEEEEEEccccEEEEEEcccccEEEEccccccEEEEEccccccEEEEEEEccEEEEECcccccEEEEcccccccEEEEEEcccccCEEEECc
MDYDDRNFYVHKMMFITNTKWVNYIFLVVHFWYALSHHVAAQMLLFATSKDIRIANLSRPLKPVTIIKDLEEGAAIDYYYKKSMVCWTDHGTEMISCCTFDGNNVGSKHNVITNGLITPDGLAIDWLTEKLYWTDSETNKLEVSSLDGKKRKVLYWEDIDQPRAIASYKLPTIEVEHPDGVAVDWVARNLYWTDTGTDRIEVCRLEGTHRKVLVNTDLVEPRAITLSPAHGYLFWSDWNEKRPKIERSLLNGGERVLLVKDRLGWPNGITLDVDNEKLYWCDAKTDKIEMIDFDGNNRRELINENLPHVFGISLLGDYVYWTDWQRRSIDRVNKITGNDREVIIERSCTGV**R***
xxxxxxxxxxxxxxxxxxxxHHHHHHHHHHHHHHHHHHHHxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MDYDDRNFYVHKMMFITNTKWVNYIFLVVHFWYALSHHVAAQMLLFATSKDIRIANLSRPLKPVTIIKDLEEGAAIDYYYKKSMVCWTDHGTEMISCCTFDGNNVGSKHNVITNGLITPDGLAIDWLTEKLYWTDSETNKLEVSSLDGKKRKVLYWEDIDQPRAIASYKLPTIEVEHPDGVAVDWVARNLYWTDTGTDRIEVCRLEGTHRKVLVNTDLVEPRAITLSPAHGYLFWSDWNEKRPKIERSLLNGGERVLLVKDRLGWPNGITLDVDNEKLYWCDAKTDKIEMIDFDGNNRRELINENLPHVFGISLLGDYVYWTDWQRRSIDRVNKITGNDREVIIERSCTGVTRRRTR

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Low-density lipoprotein receptor-related protein 6 Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Required for posterior patterning of the epiblast during gastrulation.confidentO88572
Low-density lipoprotein receptor-related protein 6 Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Required for posterior patterning of the epiblast during gastrulation.confidentO75581

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0051049 [BP]regulation of transportprobableGO:0008150, GO:0032879, GO:0065007, GO:0050789
GO:0030229 [MF]very-low-density lipoprotein particle receptor activityprobableGO:0038024, GO:0003674, GO:0030228, GO:0004872
GO:0019534 [MF]toxin transporter activityprobableGO:0005215, GO:0003674
GO:0090263 [BP]positive regulation of canonical Wnt receptor signaling pathwayprobableGO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0030111, GO:0050794, GO:0023056, GO:0030177, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0060828, GO:0048522
GO:0030178 [BP]negative regulation of Wnt receptor signaling pathwayprobableGO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0030111, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0046850 [BP]regulation of bone remodelingprobableGO:0008150, GO:0034103, GO:0065007, GO:0050789, GO:0051239
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0014033 [BP]neural crest cell differentiationprobableGO:0032502, GO:0048762, GO:0048863, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0009888, GO:0008150, GO:0048513, GO:0044763, GO:0048731, GO:0060485, GO:0009987, GO:0007275, GO:0044699, GO:0048856
GO:0060603 [BP]mammary gland duct morphogenesisprobableGO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0060443, GO:0048513, GO:0048729, GO:0022612, GO:0030879, GO:0032502, GO:0032501, GO:0035239, GO:0060429, GO:0009888, GO:0044767, GO:0008150, GO:0060562, GO:0035295, GO:0044707, GO:0048856, GO:0048731, GO:0048732, GO:0061180
GO:0006007 [BP]glucose catabolic processprobableGO:0071704, GO:0019320, GO:1901575, GO:0005975, GO:0044238, GO:0046365, GO:0005996, GO:0019318, GO:0016052, GO:0008150, GO:0008152, GO:0044723, GO:0006006, GO:0009056, GO:0044724
GO:0002053 [BP]positive regulation of mesenchymal cell proliferationprobableGO:0008284, GO:0042127, GO:0050794, GO:0050789, GO:0010464, GO:0065007, GO:2000648, GO:0048518, GO:0008150, GO:0072091, GO:0048522
GO:0042074 [BP]cell migration involved in gastrulationprobableGO:0048598, GO:0032502, GO:0016477, GO:0044707, GO:0048870, GO:0009987, GO:0032501, GO:0007369, GO:0006928, GO:0044767, GO:0009790, GO:0051674, GO:0044763, GO:0040011, GO:0051179, GO:0008150, GO:0001667, GO:0009653, GO:0007275, GO:0044699, GO:0048856
GO:0045177 [CC]apical part of cellprobableGO:0005575, GO:0044464, GO:0005623
GO:0005901 [CC]caveolaprobableGO:0045121, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0060348 [BP]bone developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0001501, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0006898 [BP]receptor-mediated endocytosisprobableGO:0006897, GO:0016192, GO:0006810, GO:0008150, GO:0051234, GO:0051179
GO:0008217 [BP]regulation of blood pressureprobableGO:0032501, GO:0044707, GO:0008015, GO:0003013, GO:0008150, GO:0065007, GO:0065008, GO:0044699, GO:0003008
GO:0043065 [BP]positive regulation of apoptotic processprobableGO:0050794, GO:0050789, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0019210 [MF]kinase inhibitor activityprobableGO:0030234, GO:0004857, GO:0003674, GO:0019207
GO:2000055 [BP]positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specificationprobableGO:2000053, GO:0050793, GO:0009967, GO:0048584, GO:0048583, GO:0030111, GO:0050794, GO:0023056, GO:0009966, GO:0030177, GO:2000026, GO:0008150, GO:0051239, GO:0023051, GO:0048518, GO:0065007, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0044765 [BP]single-organism transportprobableGO:0051234, GO:0006810, GO:0008150, GO:0051179, GO:0044699
GO:0071936 [MF]coreceptor activity involved in Wnt receptor signaling pathwayprobableGO:0038023, GO:0060089, GO:0003674, GO:0004872, GO:0004871, GO:0015026
GO:0005041 [MF]low-density lipoprotein receptor activityprobableGO:0038024, GO:0003674, GO:0030228, GO:0004872
GO:0005769 [CC]early endosomeprobableGO:0005737, GO:0043231, GO:0043227, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0005768, GO:0043226
GO:0016023 [CC]cytoplasmic membrane-bounded vesicleprobableGO:0005737, GO:0031982, GO:0031410, GO:0044464, GO:0044444, GO:0005623, GO:0031988, GO:0005575, GO:0043229, GO:0044424, GO:0005622, GO:0043227, GO:0043226, GO:0043231
GO:0045668 [BP]negative regulation of osteoblast differentiationprobableGO:0051093, GO:0050793, GO:0045595, GO:0050794, GO:0008150, GO:0045596, GO:0045667, GO:0065007, GO:0051239, GO:0048519, GO:0030278, GO:0050789, GO:0048523
GO:0014029 [BP]neural crest formationprobableGO:0048863, GO:0030154, GO:0048468, GO:0009790, GO:0009792, GO:0009653, GO:0007275, GO:0044699, GO:0014031, GO:0048864, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0008150, GO:0048513, GO:0071840, GO:0043009, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0000904, GO:0044763, GO:0060485, GO:0044707, GO:0048856, GO:0001837, GO:0048731
GO:0045840 [BP]positive regulation of mitosisprobableGO:0051130, GO:0090068, GO:0007346, GO:0045787, GO:0051726, GO:0010638, GO:0033043, GO:0010564, GO:0050794, GO:0051783, GO:0065007, GO:0008150, GO:0051785, GO:0048518, GO:0051128, GO:0007088, GO:0050789, GO:0048522
GO:0035426 [BP]extracellular matrix-cell signalingprobableGO:0044700, GO:0009987, GO:0008150, GO:0023052, GO:0007154, GO:0044763, GO:0044699
GO:0060070 [BP]canonical Wnt receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0009987, GO:0008150, GO:0050896, GO:0016055, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007154, GO:0050789, GO:0044699
GO:0009952 [BP]anterior/posterior pattern specificationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0051960 [BP]regulation of nervous system developmentprobableGO:0050793, GO:0008150, GO:0065007, GO:0051239, GO:2000026, GO:0050789
GO:0001944 [BP]vasculature developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0005109 [MF]frizzled bindingprobableGO:0001664, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0030326 [BP]embryonic limb morphogenesisprobableGO:0048598, GO:0032502, GO:0035108, GO:0044707, GO:0060173, GO:0035107, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0044699, GO:0035113, GO:0009653, GO:0007275, GO:0048736, GO:0048856
GO:0045202 [CC]synapseprobableGO:0005575
GO:0071901 [BP]negative regulation of protein serine/threonine kinase activityprobableGO:0033673, GO:0051348, GO:0019220, GO:0080090, GO:0019222, GO:0031324, GO:0031323, GO:0031399, GO:0009892, GO:0071900, GO:0043086, GO:0051248, GO:0010605, GO:0010563, GO:0051246, GO:0050789, GO:0065007, GO:0043549, GO:0044092, GO:0048519, GO:0065009, GO:0006469, GO:0045936, GO:0060255, GO:0050790, GO:0050794, GO:0051174, GO:0045859, GO:0042326, GO:0008150, GO:0042325, GO:0032269, GO:0032268, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0048523
GO:0051091 [BP]positive regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0051252, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:0044093, GO:2001141, GO:0008150, GO:0065009, GO:0010468
GO:0071397 [BP]cellular response to cholesterolprobableGO:1901700, GO:1901701, GO:0051716, GO:0070723, GO:0071407, GO:0050896, GO:0009987, GO:0071396, GO:0008150, GO:0071310, GO:0044763, GO:0044699, GO:0070887, GO:0033993, GO:0042221, GO:0036315, GO:0036314, GO:0097305, GO:0010033, GO:0014070, GO:0097306
GO:0032844 [BP]regulation of homeostatic processprobableGO:0008150, GO:0065007, GO:0050789
GO:0005770 [CC]late endosomeprobableGO:0005737, GO:0043231, GO:0043227, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0005768, GO:0043226
GO:0010243 [BP]response to organic nitrogenprobableGO:0009719, GO:0050896, GO:1901698, GO:0008150, GO:0042221, GO:0010033
GO:0048705 [BP]skeletal system morphogenesisprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0043235 [CC]receptor complexprobableGO:0043234, GO:0005575, GO:0032991
GO:0048646 [BP]anatomical structure formation involved in morphogenesisprobableGO:0032502, GO:0009653, GO:0008150, GO:0048856
GO:0044446 [CC]intracellular organelle partprobableGO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043226, GO:0044422
GO:0060042 [BP]retina morphogenesis in camera-type eyeprobableGO:0032502, GO:0032501, GO:0009887, GO:0048856, GO:0044707, GO:0007423, GO:0048592, GO:0048593, GO:0044767, GO:0048513, GO:0001654, GO:0060041, GO:0048731, GO:0008150, GO:0009653, GO:0043010, GO:0007275, GO:0044699
GO:0034392 [BP]negative regulation of smooth muscle cell apoptotic processprobableGO:0034391, GO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0043066, GO:0065007, GO:0060548, GO:0010660, GO:0010656, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0005739 [CC]mitochondrionprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0009986 [CC]cell surfaceprobableGO:0005575, GO:0044464, GO:0005623
GO:0071813 [MF]lipoprotein particle bindingprobableGO:0003674, GO:0071814, GO:0005488
GO:0048754 [BP]branching morphogenesis of an epithelial tubeprobableGO:0032502, GO:0002009, GO:0032501, GO:0035239, GO:0044707, GO:0061138, GO:0060429, GO:0009888, GO:0044767, GO:0001763, GO:0008150, GO:0048729, GO:0060562, GO:0035295, GO:0009653, GO:0007275, GO:0044699, GO:0048856
GO:0046907 [BP]intracellular transportprobableGO:0009987, GO:0006810, GO:0044763, GO:0051649, GO:0008150, GO:0051234, GO:0051179, GO:0044699, GO:0051641
GO:0044332 [BP]Wnt receptor signaling pathway involved in dorsal/ventral axis specificationprobableGO:0023052, GO:0007165, GO:0007166, GO:0009798, GO:0050789, GO:0044699, GO:0007389, GO:0051716, GO:0007275, GO:0065007, GO:0032502, GO:0032501, GO:0009987, GO:0050794, GO:0008150, GO:0003002, GO:0007154, GO:0044700, GO:0009953, GO:0044707, GO:0009950, GO:0050896, GO:0016055, GO:0044763
GO:0005615 [CC]extracellular spaceprobableGO:0005575, GO:0005576, GO:0044421
GO:0005794 [CC]Golgi apparatusprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0048878 [BP]chemical homeostasisprobableGO:0042592, GO:0008150, GO:0065008, GO:0065007
GO:0045600 [BP]positive regulation of fat cell differentiationprobableGO:0051094, GO:0050793, GO:0050794, GO:0045597, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0045598, GO:0050789, GO:0048522
GO:0042813 [MF]Wnt-activated receptor activityprobableGO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871
GO:0017147 [MF]Wnt-protein bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0007155 [BP]cell adhesionprobableGO:0008150, GO:0009987, GO:0022610, GO:0044763, GO:0044699
GO:0007399 [BP]nervous system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0015031 [BP]protein transportprobableGO:0033036, GO:0008104, GO:0006810, GO:0045184, GO:0008150, GO:0071702, GO:0051234, GO:0051179
GO:0005578 [CC]proteinaceous extracellular matrixprobableGO:0005575, GO:0005576, GO:0044421, GO:0031012

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3S94, chain A
Confidence level:very confident
Coverage over the Query: 42-355
View the alignment between query and template
View the model in PyMOL
Template: 3M0C, chain C
Confidence level:very confident
Coverage over the Query: 13-157,174-282
View the alignment between query and template
View the model in PyMOL